{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:10:01Z","timestamp":1790730601850,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Special Program of Clinical Research in Health Industry, Shanghai Municipal Health Commission","award":["201840343"],"award-info":[{"award-number":["201840343"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00261-020-02676-3","type":"journal-article","created":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T09:24:55Z","timestamp":1596273895000},"page":"623-635","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["S100A4 overexpression in pancreatic ductal adenocarcinoma: imaging biomarkers from whole-tumor evaluation with MRI and texture analysis"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8470-9567","authenticated-orcid":false,"given":"Liang","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongkui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licheng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqian","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5769-925X","authenticated-orcid":false,"given":"Mengsu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,1]]},"reference":[{"key":"2676_CR1","doi-asserted-by":"publisher","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","volume":"21","author":"J Kleeff","year":"2016","unstructured":"Kleeff J, Korc M, Apte M, et al (2016) Pancreatic cancer. Nat Rev Dis Primers 21:16022. https:\/\/doi.org\/10.1038\/nrdp.2016.22","journal-title":"Nat Rev Dis Primers"},{"key":"2676_CR2","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, et al (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74:2913\u20132921. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0155","journal-title":"Cancer Res"},{"key":"2676_CR3","unstructured":"Tempero M, Malafa M, Al-Hawary M, et al (2020) Pancreatic Adenocarcinoma, Version 1.2020, NCCN Clinical Practice Guidelines in Oncology. National Comprehensive Cancer Network. http:\/\/www.nccn.org\/. \u00a0Accessed March 27 2020"},{"key":"2676_CR4","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1200\/JOP.2016.015818","volume":"12","author":"S Tsai","year":"2016","unstructured":"Tsai S, Erickson BA, Dua K, et al (2016) Evolution of the Management of Resectable Pancreatic Cancer. J Oncol Pract 12:772\u2013778. https:\/\/doi.org\/10.1200\/JOP.2016.015818","journal-title":"J Oncol Pract"},{"key":"2676_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1001\/jama.297.3.267","volume":"297","author":"H Oettle","year":"2007","unstructured":"Oettle H, Post S, Neuhaus P, et al (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297:267\u2013277. https:\/\/doi.org\/10.1001\/jama.297.3.267","journal-title":"JAMA"},{"key":"2676_CR6","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/SLA.0000000000003143","volume":"272","author":"SB Dreyer","year":"2020","unstructured":"Dreyer SB, Pinese M, Jamieson NB, et al (2020) Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer. Ann Surg\u00a0272:366\u2013376.\u00a0https:\/\/doi.org\/10.1097\/SLA.0000000000003143","journal-title":"Ann Surg"},{"key":"2676_CR7","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.hpb.2016.05.004","volume":"18","author":"W Petrushnko","year":"2016","unstructured":"Petrushnko W, Gundara JS, De Reuver PR, et al (2016) Systematic review of peri-operative prognostic biomarkers in pancreatic ductal adenocarcinoma. HPB (Oxford) 18:652\u2013663. https:\/\/doi.org\/10.1016\/j.hpb.2016.05.004","journal-title":"HPB (Oxford)"},{"key":"2676_CR8","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ejso.2007.04.009","volume":"34","author":"I Salama","year":"2008","unstructured":"Salama I, Malone PS, Mihaimeed F, et al (2008) A review of the S100 proteins in cancer. Eur J Surg Oncol 34:357\u2013364. https:\/\/doi.org\/10.1016\/j.ejso.2007.04.009","journal-title":"Eur J Surg Oncol"},{"key":"2676_CR9","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1038\/sj.bjc.6602613","volume":"92","author":"DM Helfman","year":"2005","unstructured":"Helfman DM, Kim EJ, Lukanidin E, et al (2005) The metastasis associated protein S100A4: role in tumour progression and metastasis. Br J Cancer 92:1955\u20131958. https:\/\/doi.org\/10.1038\/sj.bjc.6602613","journal-title":"Br J Cancer"},{"key":"2676_CR10","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/MPA.0000000000000097","volume":"43","author":"SH Lee","year":"2014","unstructured":"Lee SH, Kim H, Hwang JH, et al (2014) CD24 and S100A4 expression in resectable pancreatic cancers with earlier disease recurrence and poor survival. Pancreas 43:380\u2013388. https:\/\/doi.org\/10.1097\/MPA.0000000000000097","journal-title":"Pancreas"},{"key":"2676_CR11","doi-asserted-by":"publisher","first-page":"e96441","DOI":"10.1371\/journal.pone.0096441","volume":"9","author":"X Xu","year":"2014","unstructured":"Xu X, Su B, Xie C, et al (2014) Sonic hedgehog-Gli1 signaling pathway regulates the epithelial mesenchymal transition (EMT) by mediating a new target gene, S100A4, in pancreatic cancer cells. PLoS One 9:e96441. https:\/\/doi.org\/10.1371\/journal.pone.0096441","journal-title":"PLoS One"},{"key":"2676_CR12","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.surg.2013.05.004","volume":"154","author":"S Yamada","year":"2013","unstructured":"Yamada S, Fuchs BC, Fujii T, et al (2013) Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer. Surgery 154:946\u2013954. https:\/\/doi.org\/10.1016\/j.surg.2013.05.004","journal-title":"Surgery"},{"key":"2676_CR13","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1097\/MPA.0b013e31828804e7","volume":"42","author":"N Tsukamoto","year":"2013","unstructured":"Tsukamoto N, Egawa S, Akada M, et al (2013) The expression of S100A4 in human pancreatic cancer is associated with invasion. Pancreas 42:1027\u20131033. https:\/\/doi.org\/10.1097\/MPA.0b013e31828804e7","journal-title":"Pancreas"},{"key":"2676_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0002-9440(10)64347-7","volume":"160","author":"C Rosty","year":"2002","unstructured":"Rosty C, Ueki T, Argani P, et al (2002) Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. Am J Pathol 160:45\u201350. https:\/\/doi.org\/10.1016\/S0002-9440(10)64347-7","journal-title":"Am J Pathol"},{"key":"2676_CR15","doi-asserted-by":"publisher","first-page":"S159","DOI":"10.4103\/0973-1482.172582","volume":"14","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Li Z, Ding Y, et al (2018) Overexpression of S100A4 protein may be associated with the development and progression of pancreatic cancer. J Cancer Res Ther 14:S159\u2013S166. https:\/\/doi.org\/10.4103\/0973-1482.172582","journal-title":"J Cancer Res Ther"},{"key":"2676_CR16","first-page":"13284","volume":"8","author":"G Ma","year":"2015","unstructured":"Ma G, Sun Y, Fu S (2015) Evaluation of S100A4 mRNA in EUS-FNA specimens for the assessment of chemosensitivity to gemcitabine from patients with unresectable pancreatic cancer. Int J Clin Exp Pathol 8:13284\u201313288","journal-title":"Int J Clin Exp Pathol"},{"key":"2676_CR17","doi-asserted-by":"publisher","first-page":"6786","DOI":"10.1158\/0008-5472.CAN-07-0440","volume":"67","author":"PC Mahon","year":"2007","unstructured":"Mahon PC, Baril P, Bhakta V, Chelala C, et al (2007) S100A4 contributes to the suppression of BNIP3 expression, chemoresistance, and inhibition of apoptosis in pancreatic cancer. Cancer Res 67:6786\u20136795. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-0440","journal-title":"Cancer Res"},{"key":"2676_CR18","doi-asserted-by":"publisher","first-page":"8137378","DOI":"10.1155\/2016\/8137378","volume":"2016","author":"S Huang","year":"2016","unstructured":"Huang S, Zheng J, Huang Y, et al (2016) Impact of S100A4 Expression on Clinicopathological Characteristics and Prognosis in Pancreatic Cancer: A Meta-Analysis. Dis Markers 2016:8137378. https:\/\/doi.org\/10.1155\/2016\/8137378","journal-title":"Dis Markers"},{"key":"2676_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1515\/rjim-2016-0002","volume":"54","author":"A Kalogeraki","year":"2016","unstructured":"Kalogeraki A, Papadakis GZ, Tamiolakis D, et al (2016) EUS - Fine- Needle Aspiration Biopsy (FNAB) in the Diagnosis of Pancreatic Adenocarcinoma: A Review. Rom J Intern Med 54:24\u201330. https:\/\/doi.org\/10.1515\/rjim-2016-0002","journal-title":"Rom J Intern Med"},{"key":"2676_CR20","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1136\/gutjnl-2017-315154","volume":"67","author":"JY Bang","year":"2018","unstructured":"Bang JY, Hebert-Magee S, Navaneethan U, et al (2018) EUS-guided fine needle biopsy of pancreatic masses can yield true histology. Gut 67:2081\u20132084. https:\/\/doi.org\/10.1136\/gutjnl-2017-315154","journal-title":"Gut"},{"key":"2676_CR21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1102\/1470-7330.2013.0015","volume":"13","author":"B Ganeshan","year":"2013","unstructured":"Ganeshan B, Miles KA (2013) Quantifying tumour heterogeneity with CT. Cancer Imaging 13:140\u2013149. https:\/\/doi.org\/10.1102\/1470-7330.2013.0015","journal-title":"Cancer Imaging"},{"key":"2676_CR22","doi-asserted-by":"publisher","first-page":"R150","DOI":"10.1088\/0031-9155\/61\/13\/R150","volume":"61","author":"SS Yip","year":"2016","unstructured":"Yip SS, Aerts HJ (2016) Applications and limitations of radiomics. Phys Med Biol 61:R150\u201366. https:\/\/doi.org\/10.1088\/0031-9155\/61\/13\/R150","journal-title":"Phys Med Biol"},{"key":"2676_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00261-017-1380-4","volume":"43","author":"NM Kulkarni","year":"2018","unstructured":"Kulkarni NM, Hough DM, Tolat PP, et al (2018) Pancreatic adenocarcinoma: cross-sectional imaging techniques. Abdom Radiol (NY) 43:253\u2013263. https:\/\/doi.org\/10.1007\/s00261-017-1380-4","journal-title":"Abdom Radiol (NY)"},{"key":"2676_CR24","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1148\/rg.2017170056","volume":"37","author":"MG Lubner","year":"2017","unstructured":"Lubner MG, Smith AD, Sandrasegaran K, et al (2017) CT Texture Analysis: Definitions, Applications, Biologic Correlates, and Challenges. Radiographics 37:1483\u20131503. https:\/\/doi.org\/10.1148\/rg.2017170056","journal-title":"Radiographics"},{"key":"2676_CR25","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.2214\/AJR.17.19213","volume":"211","author":"CL Vendrami","year":"2018","unstructured":"Vendrami CL, Velichko YS, Miller FH, et al (2018) Differentiation of Papillary Renal Cell Carcinoma Subtypes on MRI: Qualitative and Texture Analysis. AJR Am J Roentgenol 211:1234\u20131245. https:\/\/doi.org\/10.2214\/AJR.17.19213","journal-title":"AJR Am J Roentgenol"},{"key":"2676_CR26","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: Images Are More than Pictures, They Are Data. Radiology 278:563\u2013577. https:\/\/doi.org\/10.1148\/radiol.2015151169","journal-title":"Radiology"},{"key":"2676_CR27","doi-asserted-by":"publisher","unstructured":"Hanania AN, Bantis LE, Feng Z, et al (2016) Quantitative imaging to evaluate malignant potential of IPMNs. Oncotarget 7:85776\u201385784. https:\/\/doi.org\/10.18632\/oncotarget.11769","DOI":"10.18632\/oncotarget.11769"},{"key":"2676_CR28","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJM van Griethuysen","year":"2017","unstructured":"van Griethuysen JJM, Fedorov A, Parmar C, et al (2017) Computational Radiomics System to Decode the Radiographic Phenotype. Cancer Res. 77:e104\u2013e107. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0339","journal-title":"Cancer Res."},{"key":"2676_CR29","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ejso.2018.10.050","volume":"45","author":"CB Nahm","year":"2019","unstructured":"Nahm CB, Turchini J, Jamieson N, et al (2019) Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort study. Eur J Surg Oncol 45:218\u2013224. https:\/\/doi.org\/10.1016\/j.ejso.2018.10.050","journal-title":"Eur J Surg Oncol"},{"key":"2676_CR30","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.bbrc.2009.09.096","volume":"390","author":"T Tabata","year":"2009","unstructured":"Tabata T, Tsukamoto N, Fooladi AA, et al (2009) RNA interference targeting against S100A4 suppresses cell growth and motility and induces apoptosis in human pancreatic cancer cells. Biochem Biophys Res Commun 390:475\u2013480. https:\/\/doi.org\/10.1016\/j.bbrc.2009.09.096","journal-title":"Biochem Biophys Res Commun"},{"key":"2676_CR31","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.tranon.2014.07.005","volume":"7","author":"KC Cuneo","year":"2014","unstructured":"Cuneo KC, Chenevert TL, Ben-Josef E, et al (2014) A pilot study of diffusion-weighted MRI in patients undergoing neoadjuvant chemoradiation for pancreatic cancer. Transl Oncol 7:644\u2013649. https:\/\/doi.org\/10.1016\/j.tranon.2014.07.005","journal-title":"Transl Oncol"},{"key":"2676_CR32","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1136\/gutjnl-2015-309304","volume":"64","author":"A Neesse","year":"2015","unstructured":"Neesse A, Alg\u00fcl H, Tuveson DA, et al (2015) Stromal biology and therapy in pancreatic cancer: a changing paradigm. Gut 64:1476\u20131484. https:\/\/doi.org\/10.1136\/gutjnl-2015-309304","journal-title":"Gut"},{"key":"2676_CR33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00261-014-0196-8","volume":"40","author":"L Legrand","year":"2015","unstructured":"Legrand L, Duchatelle V, Molini\u00e9 V, et al (2015) Pancreatic adenocarcinoma: MRI conspicuity and pathologic correlations. Abdom Imaging 40:85\u201394. https:\/\/doi.org\/10.1007\/s00261-014-0196-8","journal-title":"Abdom Imaging"},{"key":"2676_CR34","doi-asserted-by":"publisher","first-page":"7226","DOI":"10.1038\/s41598-018-25627-x","volume":"8","author":"G Yun","year":"2018","unstructured":"Yun G, Kim YH, Lee YJ, et al (2018) Tumor heterogeneity of pancreas head cancer assessed by CT texture analysis: association with survival outcomes after curative resection. Sci Rep 8:7226. https:\/\/doi.org\/10.1038\/s41598-018-25627-x","journal-title":"Sci Rep"},{"key":"2676_CR35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12880-017-0209-5","volume":"17","author":"A Eilaghi","year":"2017","unstructured":"Eilaghi A, Baig S, Zhang Y, et al (2017) CT texture features are associated with overall survival in pancreatic ductal adenocarcinoma - a quantitative analysis. BMC Med Imaging 17:38. https:\/\/doi.org\/10.1186\/s12880-017-0209-5","journal-title":"BMC Med Imaging"},{"key":"2676_CR36","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ejrad.2017.02.033","volume":"90","author":"C Cassinotto","year":"2017","unstructured":"Cassinotto C, Chong J, Zogopoulos G, et al (2017) Resectable pancreatic adenocarcinoma: Role of CT quantitative imaging biomarkers for predicting pathology and patient outcomes. Eur J Radiol 90:152\u2013158. https:\/\/doi.org\/10.1016\/j.ejrad.2017.02.033","journal-title":"Eur J Radiol"},{"key":"2676_CR37","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s00330-018-5662-1","volume":"29","author":"K Sandrasegaran","year":"2019","unstructured":"Sandrasegaran K, Lin Y, Asare-Sawiri M, et al (2019) CT texture analysis of pancreatic cancer. Eur Radiol 29:1067\u20131073. https:\/\/doi.org\/10.1007\/s00330-018-5662-1","journal-title":"Eur Radiol"},{"key":"2676_CR38","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ejrad.2012.10.023","volume":"82","author":"F Ng","year":"2013","unstructured":"Ng F, Kozarski R, Ganeshan B, et al (2013) Assessment of tumor heterogeneity by CT texture analysis: can the largest cross-sectional area be used as an alternative to whole tumor analysis? Eur J Radiol 82:342\u2013348. https:\/\/doi.org\/10.1016\/j.ejrad.2012.10.023","journal-title":"Eur J Radiol"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-020-02676-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-020-02676-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-020-02676-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T23:44:30Z","timestamp":1627775070000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-020-02676-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,1]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["2676"],"URL":"https:\/\/doi.org\/10.1007\/s00261-020-02676-3","relation":{},"ISSN":["2366-004X","2366-0058"],"issn-type":[{"value":"2366-004X","type":"print"},{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,1]]},"assertion":[{"value":"13 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The Ethics Committee of Zhongshan Hospital, Fudan University approved this retrospective study (No. B2018-266).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Requirement for written informed consent was conditionally waived.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}